Recent Advances in Understanding the Protein Corona of Nanoparticles and in the Formulation of "Stealthy" Nanomaterials.
anti-fouling
characterization
immunology
interface
nanoparticles
protein corona
stealth
theranostics
Journal
Frontiers in bioengineering and biotechnology
ISSN: 2296-4185
Titre abrégé: Front Bioeng Biotechnol
Pays: Switzerland
ID NLM: 101632513
Informations de publication
Date de publication:
2020
2020
Historique:
received:
03
12
2019
accepted:
19
02
2020
entrez:
21
4
2020
pubmed:
21
4
2020
medline:
21
4
2020
Statut:
epublish
Résumé
In the last decades, the staggering progress in nanotechnology brought around a wide and heterogeneous range of nanoparticle-based platforms for the diagnosis and treatment of many diseases. Most of these systems are designed to be administered intravenously. This administration route allows the nanoparticles (NPs) to widely distribute in the body and reach deep organs without invasive techniques. When these nanovectors encounter the biological environment of systemic circulation, a dynamic interplay occurs between the circulating proteins and the NPs, themselves. The set of proteins that bind to the NP surface is referred to as the protein corona (PC). PC has a critical role in making the particles easily recognized by the innate immune system, causing their quick clearance by phagocytic cells located in organs such as the lungs, liver, and spleen. For the same reason, PC defines the immunogenicity of NPs by priming the immune response to them and, ultimately, their immunological toxicity. Furthermore, the protein corona can cause the physical destabilization and agglomeration of particles. These problems induced to consider the PC only as a biological barrier to overcome in order to achieve efficient NP-based targeting. This review will discuss the latest advances in the characterization of PC, development of stealthy NP formulations, as well as the manipulation and employment of PC as an alternative resource for prolonging NP half-life, as well as its use in diagnostic applications.
Identifiants
pubmed: 32309278
doi: 10.3389/fbioe.2020.00166
pmc: PMC7145938
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
166Informations de copyright
Copyright © 2020 Rampado, Crotti, Caliceti, Pucciarelli and Agostini.
Références
Int J Pharm. 2015 Oct 15;494(1):430-44
pubmed: 26315125
J Control Release. 2015 Feb 10;199:106-13
pubmed: 25499917
J Colloid Interface Sci. 2019 Oct 1;553:540-548
pubmed: 31234127
Nanoscale. 2017 Sep 21;9(36):13651-13660
pubmed: 28875999
Mol Pharm. 2018 Nov 5;15(11):5019-5030
pubmed: 30222356
Nanomedicine. 2018 Oct;14(7):2295-2305
pubmed: 30059754
ACS Nano. 2018 Oct 23;12(10):10130-10141
pubmed: 30117736
Expert Opin Drug Deliv. 2019 Jun;16(6):563-566
pubmed: 31001991
Nat Nanotechnol. 2013 Feb;8(2):137-43
pubmed: 23334168
Soft Matter. 2019 Jan 28;15(4):709-720
pubmed: 30624437
ACS Nano. 2018 Jul 24;12(7):7292-7300
pubmed: 29953205
Nat Nanotechnol. 2013 Oct;8(10):772-81
pubmed: 24056901
Biomaterials. 2017 Jan;115:1-8
pubmed: 27871002
J Control Release. 2016 Feb 28;224:136-145
pubmed: 26780172
Curr Opin Biotechnol. 2017 Aug;46:106-113
pubmed: 28301820
Nat Biotechnol. 2015 Sep;33(9):941-51
pubmed: 26348965
Nature. 1964 Nov 14;204:701-3
pubmed: 14236308
Theranostics. 2018 Jan 5;8(4):1131-1145
pubmed: 29464004
Sci Rep. 2017 Sep 5;7(1):10542
pubmed: 28874846
Small. 2019 Dec;15(49):e1903296
pubmed: 31709707
Nanoscale. 2017 Oct 5;9(38):14581-14591
pubmed: 28932838
Nanoscale. 2015 Sep 7;7(33):13958-66
pubmed: 26222625
Biomacromolecules. 2019 Aug 12;20(8):2989-2999
pubmed: 31268685
Anal Bioanal Chem. 2019 Jul;411(19):4313-4326
pubmed: 30758528
Nat Nanotechnol. 2016 Apr;11(4):372-7
pubmed: 26878141
Acta Biomater. 2018 Apr 15;71:420-431
pubmed: 29524674
ACS Nano. 2015 Aug 25;9(8):8142-56
pubmed: 26135229
Nanoscale. 2018 Jan 18;10(3):1256-1264
pubmed: 29292433
Nanoscale. 2015 Jun 7;7(21):9806-15
pubmed: 25962428
Int J Pharm. 2017 Nov 5;532(2):769-778
pubmed: 28450168
Biomacromolecules. 2019 Mar 11;20(3):1375-1384
pubmed: 30694655
Sensors (Basel). 2012 Nov 27;12(12):16420-32
pubmed: 23443386
Nat Mater. 2016 Sep;15(9):1037-46
pubmed: 27213956
Nat Commun. 2018 Oct 31;9(1):4548
pubmed: 30382085
ACS Nano. 2015 Mar 24;9(3):2876-85
pubmed: 25712076
Small. 2017 Aug;13(29):
pubmed: 28582610
Adv Exp Med Biol. 2017;947:173-206
pubmed: 28168669
Biomater Sci. 2017 Feb 28;5(3):378-387
pubmed: 28133653
Nanomaterials (Basel). 2018 Aug 21;8(9):
pubmed: 30134564
Langmuir. 2018 Sep 18;34(37):10817-10827
pubmed: 30132674
ACS Nano. 2016 Jan 26;10(1):1189-200
pubmed: 26720275
Nanoscale. 2019 Jul 28;11(28):13576-13586
pubmed: 31290914
Angew Chem Int Ed Engl. 2017 Jun 12;56(25):7088-7092
pubmed: 28455941
Nanomedicine (Lond). 2016 Jan;11(1):81-100
pubmed: 26653875
Acta Pharm Sin B. 2019 Jul;9(4):675-689
pubmed: 31384529
Adv Mater. 2019 Jan;31(4):e1803335
pubmed: 30488990
Nanomedicine (Lond). 2015 Jul;10(12):1923-40
pubmed: 26139126
Expert Opin Drug Deliv. 2015 May;12(5):793-812
pubmed: 25518870
Nanoscale. 2016 Apr 7;8(13):6948-57
pubmed: 26961355
Langmuir. 2017 Nov 14;33(45):12926-12933
pubmed: 29022719
Macromol Biosci. 2018 Sep;18(9):e1800075
pubmed: 29943446
ACS Appl Mater Interfaces. 2015 Apr 1;7(12):6819-27
pubmed: 25757512
Environ Sci Nano. 2019 Apr 1;6(4):1089-1098
pubmed: 31304020
Toxicol Appl Pharmacol. 2016 May 15;299:53-7
pubmed: 26592323
Blood. 1980 Jan;55(1):156-9
pubmed: 7350935
Nanoscale. 2018 Feb 1;10(5):2461-2472
pubmed: 29336463
ACS Appl Mater Interfaces. 2019 May 1;11(17):15262-15275
pubmed: 30964624
ACS Nano. 2016 Apr 26;10(4):4421-30
pubmed: 27040442
J Control Release. 2012 Jun 10;160(2):117-34
pubmed: 22484195
Biomaterials. 2017 Dec;147:155-168
pubmed: 28946131
J Control Release. 2016 Oct 28;240:332-348
pubmed: 26774224
Langmuir. 2019 Jul 2;35(26):8799-8805
pubmed: 31177786
Langmuir. 2015 Oct 6;31(39):10764-73
pubmed: 26378619
Nanotechnology. 2016 Feb 26;27(8):085106
pubmed: 26820630
Langmuir. 2011 Jun 7;27(11):6794-800
pubmed: 21528934
Adv Drug Deliv Rev. 2016 Apr 1;99(Pt A):28-51
pubmed: 26456916
Nanoscale. 2019 Jan 31;11(5):2306-2316
pubmed: 30662985
Nanomedicine (Lond). 2018 Feb;13(4):407-422
pubmed: 29345202
Nanoscale. 2017 Jan 7;9(1):349-354
pubmed: 27924334
Science. 1994 Mar 18;263(5153):1600-3
pubmed: 8128245
Nat Commun. 2019 Aug 8;10(1):3561
pubmed: 31395892
Drug Deliv. 2015 Feb;22(2):182-90
pubmed: 24215373
ACS Appl Mater Interfaces. 2018 Dec 12;10(49):41917-41923
pubmed: 30426737
Bioconjug Chem. 2018 Nov 21;29(11):3923-3934
pubmed: 30347973
J Mater Chem B. 2018 Apr 21;6(15):2204-2216
pubmed: 30294445
Nanomedicine (Lond). 2017 Nov;12(22):2757-2769
pubmed: 29017387
Nanoscale. 2018 Jan 18;10(3):1228-1233
pubmed: 29292453
ACS Nano. 2017 Mar 28;11(3):3262-3273
pubmed: 28264157
Nanoscale. 2019 May 9;11(18):8760-8775
pubmed: 30793730
Acta Biomater. 2018 Aug;76:217-224
pubmed: 29885856
ACS Appl Mater Interfaces. 2016 Feb;8(7):4385-98
pubmed: 26835968
Acta Pharm Sin B. 2019 Mar;9(2):397-409
pubmed: 30972285
Biomater Sci. 2018 Sep 25;6(10):2681-2693
pubmed: 30151516
J Control Release. 2018 Oct 10;287:121-131
pubmed: 30138715
P T. 2017 Dec;42(12):742-755
pubmed: 29234213
Drug Deliv. 2018 Nov;25(1):1932-1942
pubmed: 30472899
Beilstein J Nanotechnol. 2019 May 6;10:1002-1015
pubmed: 31165027